Showing results (41-50 of 93) with videos related to
Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|July 14, 1998
Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosaP D Lister, W E Sanders, C C SandersAntimicrobial Agents and Chemotherapy|December 1, 1988
Heterogeneity of class I beta-lactamase expression in clinical isolates of Pseudomonas aeruginosaC C Sanders, M L Gates, W E SandersAntimicrobial Agents and Chemotherapy|February 1, 1993
Decimal assay for additivity of drugs permits delineation of synergy and antagonismC C Sanders, W E Sanders, E S MolandThe Journal of Hand Surgery|November 1, 1990
Acute pulmonary edema associated with use of low-molecular weight dextran for prevention of microvascular thrombosisK J Kitziger, W E Sanders, C P AndrewsAntimicrobial Agents and Chemotherapy|July 1, 1995
Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosisS J Cavalieri, J R Biehle, W E SandersAntimicrobial Agents and Chemotherapy|June 1, 1979
In vitro activity of furazlocillin (Bay k 4999) compared with those of mezlocillin, piperacillin, and standard beta-lactam antibioticsT D Gootz, C C Sanders, W E SandersAntimicrobial Agents and Chemotherapy|December 1, 1978
Comparison of 5-episisomicin (Sch 22591), gentamicin, sisomicin, and tobramycin in treatment of experimental Pseudomonas infections in miceR V Goering, C C Sanders, W E SandersAntimicrobial Agents and Chemotherapy|June 1, 1982
In vitro antagonism of beta-lactam antibiotics by cefoxitinC C Sanders, W E Sanders, R V GoeringEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1995
Fluoroquinolone resistance in staphylococci: new challengesC C Sanders, W E Sanders, K S ThomsonThe American Journal of Medicine|July 1, 1997
Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilliJ D Pitout, C C Sanders, W E SandersPageof 10